Home

Home

Medi-Clinic steps into Europe

Last August, when the South African hospital group Medi-Clinic Corporation acquired Hirslanden, Switzerland’s biggest private hospital group, the company not only took its first step into Europe, but progressed its strategy for the geographical expansion of its core business – acute medicine ‘in conjunction with superior nursing care’.

‘Hirslanden has found a long-time strategic partner that has the same focus as us,’ said Dr Robert Bider, Hirslanden’s CEO since 1990. ‘We are convinced that this partnership holds great potential for the future.’ The patients are unaware of a change in ownership; the logo has been retained; the hospitals are characterised by the local market and legislation and the same, as well as enhanced, level of care, with no effects on the staff. There are no plans to sell off any of the hospitals.
Robert Bider said interest in further Swiss acquisitions is keen, but Medi-Clinic wants to tackle international growth systematically. ‘Concepts are currently being developed. Structures and processes must be compatible so that the synergy can be exploited, and experience and knowledge exchanged. Access to teaching and research is essential for private institutions, but difficult where the university landscape is dominated by the state. Thanks to today’s modern means of communication the establishment of an international private university-related organisation appears absolutely realistic. For example, Medi-Clinic is strongly rooted in a university-linked sector. The group is directly involved in the training of specialists and in research at five medical faculties. Moreover, it is responsible for the first privately managed university medical centre in South Africa.’
Dr Edwin Hertzog, President of the Administrative Board of Medi-Clinic Corp. Ltd, and Hirslanden CEO Dr Robert Bider will report on this development at MCC Hospital World 2008 (www.hospitalworld.info).



Medi-Clinic, the S. Africa-based private hospital group, was founded in 1983 by Dr Edwin Hertzog, its present Administrative Board President, with the support of the Rembrandt Group. The corporation unites 50 hospitals (c. 7,000 beds; 13,000 staff) most of which operate the affiliated doctor system.
The Swiss Hirslanden private hospital group, established in 1990 by a Hirslanden Clinic merger with four clinics owned by the American Medical International (AMI) Group.  The group now owns 13 hospitals (c. 1,300 beds; 4,500 employees). Dr Robert Bider has been CEO since 1990. In 2007, Hirslanden changed hands from the private equity group BC Partners to the South African corporation Medi-Clinic.

This article was published on 07/01/2008

Search

 

Service

Company News

Carestream: technical infrastructure for EU funded R-bay project

Carestream Health is a major technical infrastructure provider to the EU-funded R-Bay validation project, which aims to address the uneven spread of radiologists across member states. CARESTREAM Radiology and Information Management Solutions are driving the initial test platform for the project by facilitating remote reporting of images from hospitals in Denmark, Finland and Czech Republic by clinical providers in Estonia, Lithuania and the Netherlands.

Insulin in oral capsules

At the international congress on diabetes in September, Oramed Pharmaceuticals, Inc. introduced its oral insulin capsules that might in the future replace injections patients currently have to face. Last week Oramed announced the agreement with ETI Karle Clinical Pvt. Ltd. to conduct phase 2B clinical trials for its oral insulin capsules.

Products redesigned to help patients simplify life with diabetes

Bayer HealthCare Diabetes Care unveiled the new
CONTOUR® blood glucose meter with enhanced testing features at the 44th Annual Meeting of the European Association for the Study of Diabetes in Rome, Italy.